photodynamic therapy

Type: Keyphrase
Name: photodynamic therapy
First reported Sep 29 2014 - Updated Sep 29 2014 - 1 reports

Synthesis, Properties and Drug Potential of the Photosensitive Alkyl- and Alkylsiloxy-Ligated Silicon Phthalocyanine Pc 227

The photosensitive, alkyl- and alkylsiloxy-ligated silicon phthalocyanine, SiPc[(CH2)3SH][OSi(CH3)2(CH2)3N(CH3)2], Pc 227, has been prepared and characterized. This phthalocyanine yields the experimental photodynamic therapy (PDT) drug Pc 4, SiPc[OH][OSi(CH3)2(CH2)3N(CH3)2], ... [Published RSC - Sep 29 2014]
Entities: Silicon, Synthesis, Drugs
First reported Sep 26 2014 - Updated Sep 26 2014 - 1 reports

Applicability of new degradable hypericin-polymer-conjugates as photosensitizers: principal mode of action demonstrated by in vitro models

Two series of water soluble novel conjugates of the photosensitizer hypericin were prepared and evaluated for their use as agents for photodynamic therapy, with covalently and non-covalently loaded hypericin on functionalised, hydrolytically degradable ... [Published RSC - Sep 26 2014]
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

Endobronchial Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020

Endobronchial cancer are characterized by small size, slow growth and usually misdiagnosed as asthma or chronic bronchitis due to their common symptoms. These cancers are usually benign and rare. Due to these reasons, they may remain undiagnosed for a ... [Published MyNewsDesk - Sep 25 2014]
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

Researchers from Al-Azhar University Report New Studies and Findings in the Area of Zinc Oxide Nanotechnology (Photodynamic therapy mediated...

Researchers from Al-Azhar University Report New Studies and Findings in the Area of Zinc Oxide Nanotechnology (Photodynamic therapy mediated antiproliferative activity of some metal-doped ZnO nanoparticles in human liver adenocarcinoma HepG2 ...) By a ... [Published Town Hall - Sep 25 2014]
First reported Sep 24 2014 - Updated Sep 24 2014 - 1 reports

Dual-action chemical agents improve a high-resolution and noninvasive way to detect cancer

A chemical probe that selectively and safely illuminates tumor cells can significantly boost the capabilities of an alternative bioimaging technique (red; concentration of probe one hour after injection). Credit: C. J. H. Ho et al.Concerns over toxicity ... [Published Medical Xpress - Sep 24 2014]
Entities: Tumor, Cancer, Chemical
First reported Sep 23 2014 - Updated Sep 23 2014 - 2 reports

Quantel Medical photodynamic therapy laser garners CE Mark approval

Quantel Medical (Clermont-Ferrand, France) has received CE Mark approval for its Vitra PDT photodynamic therapy laser platform in treating the ophthalmic conditions polypoidal choroidal vasculopathy (PCV) and central serous retinopathy (CSR). The company ... [Published OptoIQ - Sep 23 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

Soligenix: A Low Risk, High Return Biotech Stock

By Grant Zeng, CFAOBB:SNGXSoligenix Enter s Late Development Stage by Acquisition of Phase III-Ready Clinical ProgramOn September 3, 2014, Soligenix ( SNGX ) entered into an asset purchase agreement with Hy Biopharma, Inc. Pursuant to the agreement, Soligenix ... [Published Yahoo! Finance - Sep 23 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 2 reports

Tampa Bay Specialist Offers Two-Part Treatment for Pre-Cancerous Actinic Keratosis

Dr. Jeffrey Hunt Provides Non-Surgical Levulan(R) Kerastick(R) and BLU-U(R) Treatments to Eliminate Actinic Keratosis Skin Lesions, Which Can Potentially Develop Into Skin Cancer; This Is Also Called PDT or Photodynamic TherapyTAMPA BAY, FL--(Marketwired ... [Published Scottrade - Sep 18 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 3 reports

Quantel Medical's Vitra PDT Laser receives CE mark approval

11:55am EDTQuantel SA:Says its Quantel Medical announced CE Mark approval for its Vitra PDT photodynamic therapy laser platform, for the treatment of polypoidal choroidal vasculopathy (PCV) and central serous retinopathy.Quantel Medical is a division ... [Published Reuters - Sep 12 2014]
Entities: Quantel SA, Vitra, CE-mark, Laser
First reported Sep 05 2014 - Updated Sep 05 2014 - 2 reports

Soligenix Acquires Phase-3-Ready Oncology Program

Soligenix Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced the acquisition of a novel orphan drug candidate, known as SGX301 (synthetic hypericin). ... [Published Drug Discovery and Development - Sep 05 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 2 reports

Photodynamic Therapy vs Cryotherapy for Actinic Keratoses

Reuters Health InformationBy David DouglasSeptember 03, 2014NEW YORK (Reuters Health) - Pooled data suggest that photodynamic therapy (PDT) is somewhat better than cryotherapy at removing actinic keratoses (AKs) from the face or scalp."PDT is a method ... [Published Diabetes Care - Sep 03 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 2 reports

Concordia, Orphan to distribute Photofrin together

Mr. Mark Thompson reportsCONCORDIA HEALTHCARE CORP. ENTERS INTO COLLABORATION AGREEMENT WITH ORPHAN CANADAConcordia Healthcare Corp.'ssubsidiary, Pinnacle Biologics Inc. has signed a collaboration agreement for Photofrin (porfimer sodium) with Orphan ... [Published Stockwatch - Sep 02 2014]

Quotes

According to the news editors, the research concluded: "This work provides an important first step in the development of a UCNP platform capable of targeted chemotherapy."
...studied in clinical trials, and so using them in photoacoustic imaging offers great potential as an alternative diagnostic technique," says Olivo. "Combining the preferential tumor uptake and high photodynamic therapy efficacy of photosensitizers with photoacoustic imaging can help achieve long-term monitoring of cancer progression and therapy under in vivo conditions."
...of a laser approved to treat these two very serious retinal conditions," commented Jean-Marc Gendre, Chief Executive Officer of Quantel Medical. "This comes at an opportune moment, as demand for PDT treatment technologies is expected to increase as the disease's true prevalence is realized. We're confident that our world-class laser technology will provide ophthalmologists a quality, cost-effective solution, and are excited to begin commercialization in Europe and Asia. This product development, supported by Novartis, Basel, Switzerland, will propose an updated solution for current and future PDT users."
"We are pleased to have FDA agreement on our Phase III protocol design in CTCL," stated Christopher J Schaber, PhD, President and CEO of Soligenix. "We are excited to move forward with this pivotal trial in an effort to address the significant unmet medical need in this orphan disease."

More Content

All (143) | News (131) | Reports (0) | Blogs (10) | Audio/Video (0) | Fact Sheets (1) | Press Releases (1)
sort by: Date | Relevance
Optical Fiber Bundles and Assemblies from Fiber... [Published AZoOptics - 23 hours ago]
Synthesis, Properties and Drug Potential of the... [Published RSC - Sep 29 2014]
Applicability of new degradable hypericin-polym... [Published RSC - Sep 26 2014]
21 ICONS South Africa to focus on Tebello Nyokong [Published Media Update South Africa - Sep 26 2014]
3 Biotech Investment Ideas That Disrupt And Div... [Published Seeking Alpha - Sep 25 2014]
New Integrated Laser Platform for Ophthalmology [Published European Medical Device Technology - Sep 25 2014]
Endobronchial Cancer Market - Global Industry A... [Published MyNewsDesk - Sep 25 2014]
Researchers from Al-Azhar University Report New... [Published Town Hall - Sep 25 2014]
Studies from University of Toronto Reveal New F... [Published HispanicBusiness.com - Sep 24 2014]
Dual-action chemical agents improve a high-reso... [Published Medical Xpress - Sep 24 2014]
Quantel Medical photodynamic therapy laser garn... [Published OptoIQ - Sep 23 2014]
Quantel Medical's Vitra™ PDT Laser Receives CE ... [Published Photonics Online - Sep 23 2014]
Soligenix: A Low Risk, High Return Biotech Stock [Published Yahoo! Finance - Sep 23 2014]
Ad hoc: Biofrontera AG files litigation against... [Published PR inside - Sep 23 2014]
Biofrontera AG: First Ameluz® sales in Central ... [Published PR inside - Sep 23 2014]
Soligenix receives FDA clearance for Phase III ... [Published PredictWallStreet - Sep 23 2014]
A novel aspect of spectroscopy for porphyrinic ... [Published RSC - Sep 19 2014]
PMB and PMEA: the best papers of 2013 [Published MedicalPhysicsWeb - Sep 19 2014]
Soligenix secured FDA clearance of Phase III tr... [Published Pharmaceutical Business Review - Sep 19 2014]
Tampa Bay Specialist Offers Two-Part Treatment ... [Published Scottrade - Sep 18 2014]
Tampa Bay Specialist Offers Two-Part Treatment ... [Published Marketwire - Breaking News Releases - Sep 18 2014]
MD Anderson Cancer Center names division head o... [Published Individual.com - Sep 18 2014]
ALLERGAN : Researchers Submit Patent Applicatio... [Published 4 Traders - Sep 17 2014]
Researchers Submit Patent Application, "Enhance... [Published 4 Traders - Sep 17 2014]
Findings on Antibodies Reported by Researchers ... [Published HispanicBusiness.com - Sep 17 2014]
Soligenix Inc announces FDA clearance of phase ... [Published Reuters - Sep 17 2014]
Soligenix Announces FDA Clearance of Phase 3 Cl... [Published Bio-Medicine - Sep 17 2014]
Intrexon : Soligenix Announces FDA Clearance of... [Published 4 Traders - Sep 17 2014]
QUEST PHARMATECH : Provides Financial Update [Published 4 Traders - Sep 16 2014]
The Sensitivity of Cancer Cells to Pheophorbide... [Published Plosone.org - Sep 16 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Tampa Bay Specialist Offers Two-Part Treatment ... [Published Marketwire - Breaking News Releases - Sep 18 2014]
Dr. Jeffrey Hunt Provides Non-Surgical Levulan(R) Kerastick(R) and BLU-U(R) Treatments to Eliminate Actinic Keratosis Skin Lesions, Which Can Potentially Develop Into Skin Cancer; This Is Also Called PDT or Photodynamic Therapy ...
Novel multifunctional nanoparticle for diagnosi... [Published the Foresight Institute - Sep 15 2014]
Schematic illustration of construction of a multifunctional nanoparticle (credit: Yuanpei Li et al./Nature Communications) A variety of nanoparticles have been designed for multiple nanomedical purposes. An article at KurzweilAI.net presents ...
Quantel Medical's Vitra™ PDT Laser Receives CE ... [Published PR Newswire: General Business - Sep 12 2014]
CLERMONT-FERRAND, France, Sept. 12, 2014 /PRNewswire/ -- Quantel Medical today announced CE Mark approval for its Vitra™ PDT photodynamic therapy laser platform, for the treatment of polypoidal choroidal vasculopathy (PCV) and central serous retinopathy ...
Concordia Healthcare Corp. announces first pati... [Published PR Newswire: Policy & Public Interest - Aug 11 2014]
TORONTO, ON and CHICAGO, IL, Aug. 11, 2014 /PRNewswire/ - Concordia Healthcare Corp. ("Concordia") (TSX: CXR) (OTCQX: CHEHF), a diverse healthcare companyfocused on legacy pharmaceutical products, orphan drugs, and medicaldevices for the diabetic population, ...
Concordia Healthcare Corp. initiates Phase 3 bi... [Published PR Newswire: Health - Aug 05 2014]
Thomas Jefferson University Hospital is first site opened, more sitesscheduled in AugustTORONTO AND CHICAGO, Aug. 5, 2014 /PRNewswire/ - Concordia Healthcare Corp. ("Concordia") (TSX: CXR) (OTCQX: CHEHF), a diverse healthcare companyfocused on legacy ...
1 2

Press Releases

sort by: Date | Relevance
The Odette Cancer Centre at Sunnybrook Health S... [Published Financial Services - Jul 15 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.